Improving the accuracy of blood pressure measuring devices in Australia: a modelled return on investment study
Zachary Desson(Hunter Medical Research Institute), Shanthi Ramanathan(Hunter Medical Research Institute), Martin McNamara(Sax Institute), Julie Redfern(Bond University), Rachael L. Morton(University of Sydney), Jacqui Webster(UNSW Sydney), Christian Delles, Andrew Searles(Hunter Medical Research Institute), Pedro Ordúñez(World Health Organization Regional Office for the Americas), Stephen J. Nicholls(Australian Centre for Heart Health), Michael Hecht Olsen(University of Copenhagen), Aletta E. Schutte(The George Institute for Global Health), Garry Jennings(The University of Sydney), Alexis Hure(Hunter Medical Research Institute), James E. Sharman(University of Tasmania), Simon Deeming(Hunter Medical Research Institute), Kerry Doyle, Gemma A. Figtree(The University of Sydney)
Cited by 1
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k